DefenCath
Drug
CorMedix Inc.
Total Payments
$70,025
Transactions
1,048
Doctors
737
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $70,025 | 1,048 | 737 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $40,163 | 6 | 57.4% |
| Food and Beverage | $29,863 | 1,042 | 42.6% |
Top Doctors Receiving Payments for DefenCath — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Nephrology | Denver, CO | $153.90 | 2 |
| , MD | Internal Medicine | Dallas, TX | $149.74 | 6 |
| , NP | Family | Slc, UT | $146.25 | 2 |
| , M.D | Nephrology | Kerrville, TX | $142.68 | 4 |
| , MD | Nephrology | Kingwood, TX | $141.36 | 7 |
| , M.D | Internal Medicine | El Paso, TX | $140.20 | 4 |
| , M.D | Nephrology | Charlottesville, VA | $137.80 | 1 |
| , M.D | Nephrology | Dallas, TX | $134.83 | 5 |
| , MD | Nephrology | Dallas, TX | $134.29 | 5 |
| , MD | Nephrology | San Antonio, TX | $132.82 | 4 |
| , M.D | Nephrology | San Antonio, TX | $132.62 | 5 |
| , MD | Nephrology | San Antonio, TX | $129.20 | 4 |
| , M.D | Internal Medicine | San Antonio, TX | $128.60 | 3 |
| , M.D | Nephrology | Dallas, TX | $128.44 | 5 |
| , M.D | Nephrology | Dallas, TX | $128.44 | 5 |
| , MD | Nephrology | Dallas, TX | $128.44 | 5 |
| , MD | Nephrology | Austin, TX | $127.89 | 2 |
| , APN | Gerontology | Evergreen Park, IL | $124.51 | 1 |
| , APRN, AGNP-C | Gerontology | Chicago, IL | $124.50 | 1 |
| , NURSE PRACTITIONER | Primary Care | Glendale Heights, IL | $124.50 | 1 |
| , APN | Nurse Practitioner | Hines, IL | $124.50 | 1 |
| , NP-C | Family | South Miami, FL | $124.07 | 2 |
| , M.D | Nephrology | Baltimore, MD | $123.30 | 1 |
| , M.D | Internal Medicine | Palm Harbor, FL | $123.08 | 5 |
| , PA-C | Physician Assistant | Plano, TX | $122.59 | 5 |
Ad
Manufacturing Companies
- CorMedix Inc. $70,025
Product Information
- Type Drug
- Total Payments $70,025
- Total Doctors 737
- Transactions 1,048
About DefenCath
DefenCath is a drug associated with $70,025 in payments to 737 healthcare providers, recorded across 1,048 transactions in the CMS Open Payments database. The primary manufacturer is CorMedix Inc..
Payment data is available from 2024 to 2024. In 2024, $70,025 was paid across 1,048 transactions to 737 doctors.
The most common payment nature for DefenCath is "Consulting Fee" ($40,163, 57.4% of total).